An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs.

Pre-exposure prophylaxis (PrEP) is an effective but understudied tool for preventing HIV among women who inject drugs (WWID). This article is the first to explore WWID's rationale for PrEP initiation (or refusal) in a real-world setting. Purposive sampling was used to recruit 25 WWID, participating...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Sexual Behavior Vol. 49; no. 6; pp. 2205 - 2213
Autores principales: Felsher, Marisa, Ziegler, Eliza, Smith, Laramie R., Sherman, Susan G., Amico, K. Rivet, Fox, Rachel, Madden, Kayla, Roth, Alexis M.
Formato: journal article
Publicado: Springer Nature Aug2020
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=144236992&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 144236992
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00040002
        ASX
      jtl: Archives of Sexual Behavior
      issn: 00040002
      maglogo: N
    pubinfo:
      dt: Aug2020
      vid: 49
      iid: 6
      pid: 237
      pub: Springer Nature
    artinfo:
      ui:
        144236992
        10.1007/s10508-020-01684-0
      ppf: 2205
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 546KB
      tig:
        atl: An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs.
      aug:
        au:
          Felsher, Marisa
          Ziegler, Eliza
          Smith, Laramie R.
          Sherman, Susan G.
          Amico, K. Rivet
          Fox, Rachel
          Madden, Kayla
          Roth, Alexis M.
        affil:
          Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market St., Room 454, 19104, Philadelphia, PA, USA
          Department of Health Management and Policy, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA
          Department of Medicine, University of California, San Diego, San Diego, CA, USA
          Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
          Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA
          Public Health Management Corporation Care Clinic, Philadelphia, PA, USA
          Prevention Point Philadelphia, Philadelphia, PA, USA
      su:
        Women's health
        Women's attitudes
        Pre-exposure prophylaxis
        HIV prevention
        Intravenous drug abusers
        Prevention of diseases in women
      sug:
        subj:
          Women's health
          Women's attitudes
          Pre-exposure prophylaxis
          HIV prevention
          Intravenous drug abusers
          Prevention of diseases in women
      keyword:
        Health belief model
        HIV
        Women who inject drugs
        Health belief model
        HIV
        Women who inject drugs
      ab: Pre-exposure prophylaxis (PrEP) is an effective but understudied tool for preventing HIV among women who inject drugs (WWID). This article is the first to explore WWID's rationale for PrEP initiation (or refusal) in a real-world setting. Purposive sampling was used to recruit 25 WWID, participating in a PrEP demonstration project operating within a syringe services program, based on whether they initiated or declined PrEP care. Content analysis of qualitative interviews was used to explore decisions to initiate PrEP (or not). We found that WWID view HIV as severe, perceive themselves to be susceptible to HIV, and believe PrEP is beneficial for HIV prevention. For some, however, real and perceived barriers outweighed benefits, leading to decisions not to initiate PrEP. Barriers included HIV stigma, fear of side effects, and needing assurance that PrEP care will be available long-term. Despite viewing PrEP as an important HIV prevention tool, not all WWID who were offered PrEP initiated it. For these women, supports to buffer perceived barriers to initiation and access to post-exposure prophylaxis may be warranted. For women who initiate, it is possible that adherence will wane if perceived risk does not remain high. Research to understand PrEP persistence is needed.
      pubtype: Academic Journal
      doctype: journal article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N